Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke

Emil Zeynalov; Susan M. Jones

doi:10.4103/1673-5374.179038

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke

DOI: 10.4103/1673-5374.179038

Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke

Emil Zeynalov

Susan M. Jones

Machine-generated Keywords：

Publication Date：2016-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：2( 392-393 )

Neural Regeneration Research

ISTICSCI

ISSN：1673-5374

Year, Vol.(Issue)：2016,11(3)